02:24:16 EDT Mon 20 May 2024
Enter Symbol
or Name
USA
CA



Biosenta Inc (2)
Symbol ZRO
Shares Issued 26,406,591
Close 2023-08-08 C$ 0.40
Market Cap C$ 10,562,636
Recent Sedar Documents

Biosenta able to produce Tri-Filler at higher rate

2023-08-08 16:15 ET - News Release

Mr. Am Gill reports

BIOSENTA ANNOUNCES FURTHER ADVANCES IN RESEARCH AND DEVELOPMENT OF TRI-FILLER™

Biosenta Inc. has further advanced in research and development of the Tri-Filler particle composed of Ca(OH)2 (calcium hydroxide) core with a CaCO3 (calcium carbonate) encapsulation. Continuing development of new methods of production of Tri-Filler by Dr. Maen Husein of the department of chemical engineering at the University of Calgary, and his team have reduced aggregation and resulted in the production of Tri-Filler particles being more uniform in shape and morphology. Additionally, using these new production methods, Tri-Filler can now be produced continuously at a higher rate than previously achieved.

The University of Calgary team continues to investigate the mechanism of encapsulation of calcium hydroxide with calcium carbonate with a view to improving Tri-Filler's performance in industrial applications and exploring Tri-Filler's ability to serve as an effective carbon sink. Preliminary testing conducted by SGS Canada Inc. using accelerated aging, indicates that Tri-Filler may have a shelf life of up to 99 years.

Dr. Mehdi Mohammadi Ashani, a postdoctoral fellow in microbiology and bioengineering at the University of Calgary, continues to study Tri-Filler on its own and in combination with other materials, to assess its efficacy against a diverse range of micro-organisms, encompassing gram-positive and gram-negative bacteria including S.aureus, P.aeruginosa and E.coli as well as fungi, including C.albecan and C.auris. Lab testing of Tri-Filler as an anti-microbial has shown very promising results. Preliminary testing points to the Tri-Filler being effective in inhibiting the growth of both gram-positive and gram-negative bacteria and fungi.

Of note, the addition of Tri-Filler in paint has demonstrated the capability to eradicate a broad selection of bacteria and more than 95 per cent of fungi within a brief 10-minute duration. This anti-microbial activity has been shown to be effective to combat Candida auris (C.auris) fungus. This specific fungus presents a substantial global health risk, given its alarming rate of spread, as identified by the Centers for Disease Control and Prevention (CDC). These preliminary results show a potential for Tri-Filler to target C.auris infections in hospital and clinic settings. Further investigation by the University of Calgary team, experimentation and refinement of the Tri-Filler particle continue.

Tri-Filler has been produced and tested in laboratory quantities and settings only. Biosenta and the University of Calgary team are in the process of assembling a bench-scale unit capable of producing Tri-Filler in more significant amounts to be used for commercial testing and as a precursor to developing and scaling up to a commercial plant.

Biosenta has identified a number of industry partners with whom Biosenta and the University of Calgary team are in various stages of talks for further research and commercialization. These partnerships will be the subject of future press releases if and as agreements with such industry partners are entered into. For certainty, while the company has had initial conversations with potential partners, these conversations are preliminary and the company has not entered into any definitive agreements with any such partners.

About Biosenta Inc.

Biosenta, a groundbreaking pioneer in the field of anti-microbial solutions, is on a mission to revolutionize the material world. The company develops cutting-edge chemical compounds designed to eliminate harmful micro-organisms such as bacteria, fungi and viruses for household and industrial uses, while ensuring safety for both humans and the environment. The company's aim is to address the escalating global health crisis of anti-microbial resistance (AMR).

The company's groundbreaking approach has birthed two main offerings:

  1. True disinfectant: Biosenta's pioneering, broad-spectrum, anti-microbial, dual-action disinfectant is recognized by Health Canada for use in the fight against COVID-19. The company designed it to be tough on germs but gentle on humans, causing no irritation or harm. With its long-lasting disinfecting power, it effectively kills bacteria, germs, mold, mildew and viruses. The company's true technology leads the charge against the threat of superbug pathogens.
  2. Tri-Filler: Biosenta's flagship product, Tri-Filler, symbolizes the company's commitment to transforming the material world. The "Tri" in Tri-Filler represents three key characteristics:
    1. Anti-microbial Power: Tri-Filler delivers impressive anti-microbial protection, preventing the regrowth of bacteria, fungi, mold and viruses. It provides a critical defence against the escalating anti-microbial Resistance (AMR) global health crisis.
    2. Material enhancement: Ingeniously engineered by encapsulating calcium hydroxide with calcium carbonate, Tri-Filler is a food-grade, biocompatible solution. It not only imparts anti-microbial properties but also enhances the strength, fire retardancy and performance of various materials including plastics, paints, coatings, textiles, drywall and concrete. It fortifies these materials against forces and stresses that could cause damage or failure. The company's accelerated aging tests show that this solution can maintain efficacy for up to an impressive 99 years.
    3. Eco-efficiency: Tri-Filler represents a significant stride toward a greener future. By incorporating CO2 in the encapsulation process, Tri-Filler aids in reducing CO2 emissions, helping businesses in achieving their sustainability goals.

Proudly Canadian, Biosenta is at the forefront of reshaping the material world for the better, tackling significant global health and environment challenges. The company is committed to making the world a safer and healthier place.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.